A novel technique for simultaneous bilateral brain infusions in a mouse model of neurodegenerative disease

Journal of Neuroscience Methods

Volumn 184, Issue 2, 2009, Pages 320-326

  Bennett, Steven P ^a,b   Boyd, Tim D ^a,b   Norden, Michelle ^a,b,c   Padmanabhan, Jaya ^a,b   Neame, Peter ^b   Wefes, Inge ^b,c   Potter, Huntington ^a,b,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Eric Pfeiffer Suncoast Alzheimer's and Gerontology Center   (United States)

Author keywords

1 Antichymotrypsin (ACT); A beta (A ); Alzheimer's disease (AD); Amyloid; Bilateral; Catheter; Infusion; Osmotic pump

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LATERAL VENTRICLE; CATHETER; CONTROLLED STUDY; HEMISPHERE; INFUSION SYSTEM; MORTALITY; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; APOLIPOPROTEINS E; BRAIN; CATHETERS, INDWELLING; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; DRUG SYNERGISM; ENCEPHALITIS; FUNCTIONAL LATERALITY; INFUSION PUMPS, IMPLANTABLE; MICE; MICE, TRANSGENIC; NEUROPHARMACOLOGY; SENILE PLAQUES; SERINE PROTEINASE INHIBITORS;

EID: 70350029602     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2009.08.021     Document Type: Article

References (14)

1. Abraham C.R. Reactive astrocytes and alpha1-antichymotrypsin in Alzheimer's disease. Neurobiol Aging 22 (2001) 931-936
2. Abraham C.R., Selkoe D.J., and Potter H. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52 (1988) 487-501
3. Bales K.R., Verina T., Cummins D.J., Du Y., Dodel R.C., Saura J., Fishman C.E., DeLong C.A., Piccardo P., Petegnief V., Ghetti B., and Paul S.M. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 96 (1999) 15233-15238
4. Das S., and Potter H. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 14 (1995) 447-456
5. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
6. Kalsheker N.A. Alpha 1-antichymotrypsin. Int J Biochem Cell Biol 28 (1996) 961-964
7. Ma J., Brewer Jr. H.B., and Potter H. Alzheimer A beta neurotoxicity: promotion by antichymotrypsin. ApoE4; inhibition by A beta-related peptides. Neurobiol Aging 17 (1996) 773-780
8. Mucke L., Yu G.Q., McConlogue L., Rockenstein E.M., Abraham C.R., and Masliah E. Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice. Am J Pathol 157 (2000) 2003-2010
9. Nilsson L.N., Bales K.R., DiCarlo G., Gordon M.N., Morgan D., Paul S.M., and Potter H. Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease. J Neurosci 21 (2001) 1444-1451
10. Padmanabhan J., Levy M., Dickson D.W., and Potter H. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Brain 129 (2006) 3020-3034
11. Selkoe D.J. Altered structural proteins in plaques and tangles: what do they tell us about the biology of Alzheimer's disease?. Neurobiol Aging 7 (1986) 425-432
12. Tanzi R.E., George-Hyslop P.S., and Gusella J.F. Molecular genetics of Alzheimer disease amyloid. J Biol Chem 266 (1991) 20579-20582
13. Wisniewski T., Castano E.M., Golabek A., Vogel T., and Frangione B. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 145 (1994) 1030-1035
14. Wisniewski T., and Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135 (1992) 235-238